Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Shirley Ryan AbilityLab
- Study ID
- NCT05568264
- Status
- Recruiting
Conditions
- Bronchopulmonary Dysplasia
- Hypoxic-Ischemic Encephalopathy
- Intraventricular Hemorrhage
- Motor Delay
- Premature Birth
Eligibility Criteria
- Sex
- ALL
- Age
- 33 Weeks - 48 Weeks
- Healthy Volunteers
- Not accepted
Interventions
- Physical Therapy intervention — OTHERThe intervention is based on five principles: active learning, caregiver engagement, environmental enrichment, strengths-based approach, and dose. The intervention will start in the NICU and continue until 12-months corrected age. Infants in the intervention group will receive up to two therapist visits per week in addition to standard of care physical therapy. Caregivers will be asked to work with their infant on activities provided by the therapist. The therapist will provide resources to support the caregiver in working on these activities with their child, and caregivers will be asked to complete the activities for as much time as possible, throughout the day. Therapists will work with caregivers to identify ways to incorporate activities into their day. Caregiver engagement and caregiver ability to complete sessions and activity recommendations will be monitored.
Study Details
Study Aims Pilot study: Due to the large recruitment goal and length of the project, the study team/PIs will evaluate the first cohort of 6-10 participants to refine study procedures and study-related materials. If no major modifications are made to the protocol as a result of this evaluation, data from these participants will be included for analysis. Aim 1: Evaluate the efficacy of an early, evidence-based, clinical experience-based therapeutic intervention (from the NICU to 12-months corrected age) on improving motor function and reducing severity of motor delays in infants at 12-months corrected age. The investigators hypothesize that the intervention group will demonstrate an average 8-point difference (0.5 standard deviation) compared to the standard of care group. \[an 8-point difference is considered a clinically meaningful difference\] Aim 2: Evaluate the early effects (i.e., before 12 months) of a therapeutic intervention, provided from NICU to 12-months corrected age, on motor function and severity of motor delay. The Investigators hypothesize that a statistically significant higher percentage of infants in the intervention group will demonstrate improved motor function and reduced severity of motor delays, compared to the standard of care group-assessed using sensors, the NSMDA and TIMP-as early as 3-months corrected age. Aim 3: Evaluate whether an early intervention that focuses on caregiver engagement improves caregiver well-being. The invetigators hypothesize that an intervention that focuses on supporting and addressing the individual needs of the caregiver will improve caregiver well-being. The investigators will evaluate these effects using the PedsQL (Family Impact Module).
Key Dates
- Start date
- Oct 1, 2022
- Status verified
- May 2025
- Primary completion
- May 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 222 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Physical Therapy InterventionInfants enrolled in this arm will receive the intervention in addition to standard of care
- No Intervention: Standard of CareInfants enrolled in this arm will receive standard of care
Primary Outcome Measure
Bayley-4 motor score at 12-months corrected age [ Time Frame: Bayley-4 motor score assessed at 12-months CA will be the primary outcome ]
Central Contacts
- Elizabeth Hoffman, DPT312-238-7711
- Sara Prokup, DPT312-238-1355
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | Project Manager |
| Children's Hospital at the University of Illinois | Chicago | Illinois | 60612 | |
| Northwestern Medicine Prentice Children's Hospital | Chicago | Illinois | 60611 | Project Manager |
Find similar trials in Chicago, IL
Related Studies
- A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature InfantsPHASE2 · Recruiting · OHB Neonatology Ltd. · Little Rock, Arkansas
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- The Periviable GOALS Decision Support ToolRecruiting · Indiana University · San Diego, California
- Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School AgeRecruiting · Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois